Contribute Try STAT+ Today

And so, another working week will soon come to an end. Not a moment too soon, yes? For those who think this may sound premature, there is a holiday tomorrow on this side of the pond, so we are getting a head start on our weekend daydreaming. Our agenda is rather modest, given the circumstances. We do hope to hang with a couple of the short people, promenade with our energetic mascot and catch up on our reading. And what about you? This is a fine time to enjoy the outdoors. You could also putter around your castle. Or reach out to someone feeling isolated. Well, whatever you do, have a grand time. Enjoy, but be safe and wear a mask. This virus will not just disappear. See you soon…

Top Trump administration health officials are seeking to reassure the public that any potential Covid-19 vaccine will only be approved if it is safe and that the fast-track process will not be influenced by political pressure, The Hill reports. To assuage some of that concern, the agency released a guidance that outlines conditions for approving a vaccine. Those include requiring any vaccine to be at least 50% more effective than a placebo in preventing the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy